CSRXP: SENATE JUDICIARY COMMITTEE CRACKS DOWN ON BIG PHARMA PATENT ABUSE
Jul 29, 2021
Unanimous, Bipartisan Passage of Bills Targeting Brand Name Drug Companies’… Read More
© 2025 CSRXP- All Rights Reserved
Updates
BIG PHARMA EARNINGS WATCH: JOHNSON & JOHNSON, NOVARTIS, ROCHE
Jul 22, 2021
New Round of Earnings Reports Show Big Pharma Companies Riding High on Massive… Read More
SECOND OPINION: PHARMA-BACKED REBATE RULE WOULD HIKE SENIOR PREMIUMS, BOOST DRUG COMPANY PROFITS
Jul 22, 2021
Big Pharma Wants Implementation of Misguided Policy that Does Nothing to Lower… Read More
THEY SAID IT! U.S. SENATE JUDICIARY SUBCOMMITTEE HIGHLIGHTS BIG PHARMA’S ANTI-COMPETITIVE PRACTICES
Jul 14, 2021
Lawmakers Showcase How Big Pharma’s Patent Abuse Drives Out-of-Control… Read More
DOSE OF REALITY: LAWMAKERS TO PROBE BIG PHARMA PATENT ABUSE AS INNOVATION EXCUSES CRUMBLE
Jul 13, 2021
U.S. Senate Judiciary Subcommittee Hearing Tuesday Will Build on Momentum for… Read More
CSRxP COMMENDS PRESIDENT BIDEN FOR RENEWED COMMITMENT TO HOLDING BIG PHARMA ACCOUNTABLE
Jul 9, 2021
Campaign Looks Forward to Working with Administration and Congress to Crack… Read More
CSRXP: OVERSIGHT REPORT ADDS TO MOMENTUM IN WASHINGTON TO HOLD BIG PHARMA ACCOUNTABLE
Jul 8, 2021
U.S. House Oversight & Reform Committee Report Shines Light on Branded… Read More
BIG PHARMA WATCH: JULY PRICE HIKES CLIMB TO 52
Jul 7, 2021
Brand Name Drug Companies Stick to Business-as-Usual in Third Major Round of… Read More
CSRxP: Big Pharma Flaunts Disregard for Rx Affordability With Third Major Round of Pandemic Price Hikes
Jul 1, 2021
Pharmaceutical Companies Increase Prices on 32 Brand Name Drugs to Start July… Read More
ICYMI: BIG PHARMA USES INFLUENCE OVER PATIENT GROUPS & ASTROTURF TACTICS TO UNDERMINE RX SOLUTIONS
Jun 30, 2021
New Report Reveals “Hidden Hand” Of Brand Name Drug Industry In case you… Read More
CSRXP APPLAUDS U.S. HOUSE PROBE INTO BIOGEN PRICING OF ADUHELM
Jun 25, 2021
Pallone and Maloney Announce Joint Investigation into Massive Price Tag on… Read More
BIG PHARMA WATCH: HEADLINES SHOW BIOGEN ADHUHELM PRICING HAS REIGNITED URGENCY TO HOLD BIG PHARMA ACCOUNTABLE
Jun 25, 2021
Coverage Highlights Backlash Over Massive Price Tag for Unproven Treatment,… Read More